Sun Pharmaceutical's vital signs: A strong dose of valuation multiples
Bolstered by an impressive performance in the global specialty business and outstanding results in the Indian market, Sun Pharmaceutical Industries, the largest pharmaceutical (pharma) company in the country, showcased a strong performance in the July-September quarter (second quarter, or Q2) of 2023-24 (FY24).
Vishal Manchanda Jainil Shah Rahul Jeewani Sun Pharma Motilal Oswal Research Prabhudas Lilladher Research
Source: rediff.com